Skip to main content
Back to Sequoia Capital

Sequoia Capital's Biotechnology Portfolio

Browse 21 Biotechnology companies funded by Sequoia Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
21
Total Funding in Biotechnology
$3.2B

Biotechnology Portfolio Companies (21)

Export
Artificial Intelligence (AI)BiotechnologyGenerative AIGeneticsHealth CareTherapeutics

Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.

San Francisco, United States
August 2021
$5.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

GondolaBio researches, develops and manufactures pharmaceutical products.

Palo Alto, United States
August 2024
$300.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologymHealthPersonal HealthPredictive AnalyticsTelehealthTherapeutics

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

Boston, United States
July 2022
$20.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

New York, United States
June 2024
$372.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalNeuroscienceRobotics

Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.

Fremont, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

South San Francisco, United States
May 2026
$115.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Cambridge, United States
March 2025
$123.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingMedicalTherapeutics

GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.

San Francisco, United States
March 2023
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

San Francisco, United States
February 2024
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsPharmaceuticalTherapeutics

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

South San Francisco, United States
January 2024
$24.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science

Athelas develops technology to monitor chronically ill patients in their homes.

Mountain View, United States
January 2022
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMedical DeviceMental HealthTherapeutics

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Palo Alto, United States
December 2021
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareLife Science

Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.

Pleasanton, United States
December 2021
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyConsumerHealth CareLife Science

Myome helps identify genes that cause disease and act based on leading science.

Palo Alto, United States
December 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Palo Alto, United States
January 2026
$550.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

PhenomeX is a provider of life sciences that have the era of the phenome as the next revolution in biology and medicine unfolds.

Emeryville, United States
January 2023
$70.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

Cambridge, United Kingdom
November 2021
$88.0M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Sequoia Capital's Full Portfolio

View all companies funded by Sequoia Capital across every industry and funding stage.

View Full Sequoia Capital Portfolio